Sign in
Taking peopleNo phase

Chewing muscle thickness after radiofrequency treatment for trigeminal neuralgia

Measures masseter muscle thickness by ultrasound after nerve ganglion treatment in trigeminal neuralgia.

Key facts

Who runs it
Başakşehir Çam & Sakura City Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment
Status
Recruiting
People taking part
30 people, planned
Started
15 Mar 2024
Planned end
15 Oct 2025
Type of study
Interventional
Treatments tested
  • Gasserian Ganglion Radiofrequency Thermocoagulation
Record updated
5 March 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with trigeminal neuralgia (sharp nerve pain in the face) who are planning radiofrequency heat treatment of the gasserian ganglion, a nerve cluster in the head. It measures the chewing (masseter) muscle by ultrasound before and after the treatment.

Age
40 Years to 85 Years
Sex
All
Disease stage
Pain that has not improved with medicines for at least 3 months.
Earlier treatment
Medicines must have been tried without enough pain relief for at least 3 months. People must be planning radiofrequency thermocoagulation of the gasserian ganglion.

Main reasons for not taking part

  • Blood clotting disorder
  • Pregnancy
  • Local or whole-body infection
  • Not able to attend follow-up visits regularly
  • Not agreeing to the ultrasound measurements

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Pain refractory to medical therapy for at least 3 months
  • Planning radiofrequency thermocoagulation of gasserian ganglion
  • Accept ultrasound measurements to be performed

Who cannot take part

  • Coagulation disorder
  • Localized or systemic infection
  • Refused to participate in the study
  • Not attending follow-ups regularly
  • Pregnancy

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 40 and 85 years old?

This trial is currently available in Türkiye.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Trigeminal neuralgia is common painful disorder in pain medicine clinics. Gasserian ganglion radiofrequency thermocoagulation is one of the treatment option in patients with trigeminal neuralgia in refractory cases. The most commonly involved branch in trigeminal neuralgia is the mandibular branch. Masseter muscle is innervated by mandibulary nerve branch of the trigeminal nerve.

Read full original descriptionShow less

The radiofrequency thermocoagulation therapy is used to ablate the affected trigeminal nerve branch and some of patients complain of subjective masseter weakness after this procedure.

In theoretical basis, muscles innervated by target nerve are affected from ablation procedure. In this study the primary aim is to evaluate the change of the masseter muscle thickness in patients treated by gasserian ganglion radiofrequency thermocoagulation. The results may also show possible functional effect of the procedure related with masseter muscle.

The group in the trial

  • Patients treated with gasserian ganglion RFT for trigeminal neuralgiaOther group

    In patients who have undergone radiofrequency thermocoagulation (RFT) of the gasserian ganglion for the treatment of trigeminal neuralgia, the thickness of the masseter muscle will be measured bilaterally, free and contracted, by ultrasound on the day of the procedure (just before the procedure) and at 1 and 3 months after the procedure.

    Treatment: Gasserian Ganglion Radiofrequency Thermocoagulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Change of the Masseter Muscle Thickness Measured by Ultrasonography After Gasser Ganglion Radiofrequency Thermocoagulation Treatment
Plain-language title
Chewing muscle thickness after radiofrequency treatment for trigeminal neuralgiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06278194, who can take part
Record updated
5 March 2025